-
公开(公告)号:BR112012008082A2
公开(公告)日:2016-03-01
申请号:BR112012008082
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:ZA201208225B
公开(公告)日:2013-07-31
申请号:ZA201208225
申请日:2012-11-01
Applicant: VERTEX PHARMA
Inventor: VERWIJS MARINUS JACOBUS , KAUSHIK RITU ROHIT , YOUNG CHRISTOPHER RYAN , ALARGOVA ROSSITZA GUEORGUIEVA , KADIYALA IRINA NIKOLAEVNA
IPC: A61K20060101 , C07D20060101
Abstract: A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.
-
公开(公告)号:ZA201200722B
公开(公告)日:2013-05-29
申请号:ZA201200722
申请日:2012-01-30
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER R , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , ZLOKARNIK GREGOR , VAN GOOR FREDRICK F
IPC: A61K20060101 , A61P20060101
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:MX2012011656A
公开(公告)日:2012-11-23
申请号:MX2012011656
申请日:2011-04-07
Applicant: VERTEX PHARMA
Inventor: KADIYALA IRINA NIKOLAEVNA , VERWIJS MARINUS JACOBUS , ALARGOVA ROSSITZA GUEORGUIEVA , KAUSHIK RITU ROHIT , YOUNG CHRISTOPHER RYAN
IPC: A61K9/20 , A61K9/16 , A61K9/28 , C07D213/75 , C07D405/12 , C07D405/14
Abstract: Una composición farmacéutica que comprende el Compuesto 1, ácido (3-(6-(1-(2, 2-difluorobenzo[d] [1, 3] dioxol-5-il)ciclopropancarb oxamido)-3-metilpiridin-2-il)benzoico), y al menos un excipiente seleccionado de: un relleno, un diluyente, un disgregante, un agente tensioactivo, un aglutinante, un deslizante y un lubricante, la composición siendo adecuada para administración oral a una paciente en la necesidad de esto para tratar una enfermedad mediada por CFTR tal como Fibrosis Cística. Métodos para tratar un paciente en a necesidad de esto incluyen la administración de una formulación farmacéutica oral del Compuesto 1 al paciente.
-
公开(公告)号:AU2011242454A1
公开(公告)日:2012-11-08
申请号:AU2011242454
申请日:2011-04-22
Applicant: VERTEX PHARMA
Inventor: VAN GOOR FREDRICK F , ALARGOVA ROSSITZA GUEORGUIEVA , ALCACIO TIM EDWARD , AREKAR SNEHA G , BINCH HAYLEY MARIE , BOTFIELD MARTYN CURTIS , FANNING LEV TYLER DEWEY , GROOTENHUIS PETER DIEDERIK JAN , HURLEY DENNIS JAMES , JOHNSTON STEVEN C , KADIYALA IRINA NIKOLAEVNA , KAUSHIK RITU ROHIT , KESHAVARZ-SHOKRI ALI , KRAWIEC MARIUSZ , LEE ELAINE CHUNGMIN , LUISI BRIAN , MEDEK ALES , MUDUNURI PRAVEEN , NUMA MEHDI , SHETH URVI JAGDISHBHAI , SILINA ALINA , SULLIVAN MARK JEFFREY , VERWIJS MARINUS JACOBUS , YANG XIAOQING , YOUNG CHRISTOPHER RYAN , ZAMAN NOREEN TASNEEM , ZHANG BEILI , ZHANG YUEGANG , ZLOKARNIK GREGOR
IPC: A61K31/4704 , A61K31/404 , A61K31/443
Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formulas I and II, optionally in combination with a Compound of Formula III and/or a Compound of Formula IV. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis.
-
公开(公告)号:AU2010282986A1
公开(公告)日:2012-02-16
申请号:AU2010282986
申请日:2010-02-18
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER R , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , ZLOKARNIK GREGOR , VAN GOOR FREDRICK F
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis( 1, 1 -dimethylethyl)-5-hydroxyphenyl]- 1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:CA2796602A1
公开(公告)日:2011-10-27
申请号:CA2796602
申请日:2011-04-22
Applicant: VERTEX PHARMA
Inventor: VAN GOOR FREDRICK F , ALARGOVA ROSSITZA GUEORGUIEVA , ALCACIO TIM EDWARD , AREKAR SNEHA G , BINCH HAYLEY MARIE , BOTFIELD MARTYN CURTIS , FANNING LEV TYLER DEWEY , GROOTENHUIS PETER DIEDERIK JAN , HURLEY DENNIS JAMES , JOHNSTON STEVEN C , KADIYALA IRINA NIKOLAEVNA , KAUSHIK RITU ROHIT , KESHAVARZ-SHOKRI ALI , KRAWIEC MARIUSZ , LEE ELAINE CHUNGMIN , LUISI BRIAN , MEDEK ALES , MUDUNURI PRAVEEN , NUMA MEHDI , SHETH URVI JAGDISHBHAI , SILINA ALINA , SULLIVAN MARK JEFFREY , VERWIJS MARINUS JACOBUS , YANG XIAOQING , YOUNG CHRISTOPHER RYAN , ZAMAN NOREEN TASNEEM , ZHANG BEILI , ZHANG YUEGANG , ZLOKARNIK GREGOR
IPC: A61K31/4704 , A61K31/404 , A61K31/443
Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formulas I and II, optionally in combination with a Compound of Formula III and/or a Compound of Formula IV. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis.
-
公开(公告)号:AU2009282419A2
公开(公告)日:2011-03-31
申请号:AU2009282419
申请日:2009-08-13
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO
IPC: A61K47/32
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
-
-
-
-
-
-